← Back to all announcements

Cancer trials recognized as best in the world

  • Published Wed Jun 8th 2016

    Canadian Cancer Trials Group earned unprecedented distinction of having two trials presented at the Plenary Session of the American Society of Clinical Oncology annual meeting

    Two cancer trials conducted by the Queen’s University-based Canadian Cancer Trials Group (CCTG) and lead scientific investigators Chris O’Callaghan and Wendy Parulekar have been recognized as among the highest impact studies in the world.

    The two trials are being included in the plenary session of the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

    “The papers that are chosen represent the best and most significant advances in cancer treatment and care, with the greatest potential influence” Dr. O’Callaghan says. “Only four papers were chosen for the ASCO plenary session out of more than 5,000 submissions - to have two selected from one research organization is a rare achievement.”

    Continue reading...